1. CR2
O offers the following Site Management
services through our affiliated clinics and
research centers.
• Study feasibility,
• Site selection & start-up (contracting and
regulatory submissions),
• Patient recruitment,
• Site management.
CR2
O offers the following Contract Research
services, backed-up by our quality infrastructure.
• Protocol development,
• Study feasibility,
• Site selection & start-up (contracting and
regulatory submissions),
• Clinical project management,
• Patient recruitment,
• Study monitoring and operations,
• Site management,
• Data management & statisticafety reporting,
• Study reporting.
Clinical Research Rotterdam
Who we are
CR2
O is an academic research organization that
focusses on managing and operating clinical trials
for vaccine-, drug-, and diagnostics development by
industry and public organizations.
Value proposition
CR2
O offers the combined
strengths of its affiliated
centers and clinical operations
capabilities as an overarching
cutting edge service provider.
Site Management services Contract Research services
Aim
A major objective of CR2
O is performing clinical
and epidemiological research projects for vaccine
industry. The transparent and knowledge-based
infrastructure of CR2
O makes it an attractive and
reliable contract partner. The management of CR2
O
includes highly qualified scientists and business
oriented clinical development professionals. This
leads to the optimal combination of scientific
expertise and industrial efficiency, satisfying the
need of pharmaceutical industry to outsource
clinical trial operations and monitoring.
Scientific network
CR2
O closely collaborates with leading clinics and
research centers throughout Europe. Through our
affiliated centers we aim to bring world-class academic
expertise in viral and other infectious diseases, with state
of the art clinical infrastructure and high quality research
facilities (e.g. BSL 2-3 research and diagnostic labs).
CR2
O participates in a worldwide network of virology
stakeholders, providing us with a unique position to
enter the field of clinical trials for infectious disease
interventions, to test new generations of vaccines,
drugs, and diagnostic approaches.

2. Clinical Research Rotterdam
Hadil Es-Sbai
Chief Executive Officer
Hadil assumed several
roles within the
pharmaceutical- and CRO
industry, thereby acquiring
extensive experience in
managing international
clinical trials within a wide
range of therapeutic areas.
Ab Osterhaus
Chief Scientific Officer
As professor of the Department
of Viroscience at Erasmus
MC Rotterdam, and professor
of Wildlife Virology and Virus
Discovery at Utrecht University,
Ab has a long track record as
scientific researcher and PI
of numerous major scientific
projects.
Meet our team
Rob Posthumus
General Counsel
With a background as head
of the legal department of
Erasmus university Medical
Center Rotterdam, Rob
acquired extensive experience
drafting, negotiating
and managing contracts
in healthcare and the
biotechnology sector.
Eric Claassen
Chief Financial Officer
Eric is 10% academic and
90% entrepreneur. He has held
numerous functions related
to research management,
valorization and business
development in life sciences
with a special emphasis on
immunology (SMBWO board
certified), microbiology.
Inquiries
For information on our services please contact
info@CR2O.nl
T: +31 6 450 77 441
CR2
O
Rotterdam Science Tower
Marconistraat 16
L-3029 AK
Rotterdam
The Netherlands
www.CR2O.nl